Together, they rebuild a stronger, more resilient you from the inside out
Acetylcysteine is indicated as adjuvant therapy for patients with abnormal, viscid, or inspissated mucous secretions in such conditions as: Chronic bronchopulmonary disease (chronic emphysema, emphysema with bronchitis, chronic asthmatic bronchitis, tuberculosis, bronchiectasis and primary amyloidosis of the lung) Acute bronchopulmonary disease (pneumonia, bronchitis, tracheobronchitis) Pulmonary complications of cystic fibrosis Tracheostomy care Pulmonary complications associated with surgery Use during anesthesia Post-traumatic chest conditions Atelectasis due to mucous obstruction Diagnostic bronchial studies (bronchograms, bronchospirometry, and bronchial wedge catheterization) After proper administration of acetylcysteine, an increased volume of liquified bronchial secretions may occur
Nach 12 Wochen Anwendung wurde eine signifikante Reduktion feiner Falten und eine Verbesserung der Hauttextur dokumentiert
Watanabe, F., Hashizume, E., Chan, G
